DOCSLIB.ORG

Bluestar Israel Equity Update Third Quarter 2014 Q2 2014 in Review & Q3 2014 Outlook

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bluestar Israel Equity Update Third Quarter 2014 Q2 2014 in Review & Q3 2014 Outlook BlueStar Israel Equity Update Third Quarter 2014 Q2 2014 in Review & Q3 2014 Outlook Major Emerging and Developed Market stock indexes rose in Q2 2014. The S&P What’s Inside 500 index gained 4.69% while the MSCI EAFE and Emerging Market Indexes were up 1.74% and 5.13%, respectively Israeli Global 1. The BlueStar Israel Global Index (“BIGI”) declined 2.08% in Q2 after rising by over Equities in Q2 6% during the Q1 2014 2014 Most major global equity benchmarks sold off in early/mid April and then recovered sharply throughout the rest of the quarter. Israeli equities did not recover in line with its Developed Market peers on account of moderation in economic growth forecasts for ® 2.-4. About the BIGI this and next year, and heightened geopolitical risks Index The BlueStar Israel Global Index and the BlueStar Israel Global Technology Index (“BIGITech”) underwent their semi-annual rebalance and reconstitution. As a result of 5. Technical Analysis increased IPO activity during the first and second quarters of 2014, BIGI added a net of 12 new constituents and BIGITech added a net of four new constituents 6. About the Israeli Global Health Care stocks were the only sector to post gains in Q2, largely on BIGITech Index account of Teva and Taro Pharmaceuticals whose shares rose by 2.5% and 26%, respectively 7. Israeli Capital The poorest performing sector within the Israeli Global Equities universe was the Markets Update Consumer Discretionary sector which declined by 46 basis points in Q2. Shares of SodaStream and Fox led this sector on the downside, decreasing by 23% and 18%, respectively 8. Israeli Economic Review & Outlook Q3 2014 began with a rally which quickly gave way to geopolitical concerns as the Israeli Defense Forces battles Hamas in Gaza in order to put an end to the threat of rocket fire from the Gaza Strip. Additional stock market volatility resulted from a U.S. 9. Geopolitical Federal Reserve report that suggested overvaluation in some sectors of the U.S. equity Environment market. Initial Q2 corporate results have been generally strong, as has U.S. economic data. We expect economics and fundamentals to take over the spotlight as we move into the end of July and the rest of Q3. BIGI® Performance (BlueStar Israel Global Index, Jan. 2010- Jun. 2014) 190 170 150 130 TA-100 S&P 500 110 BIGI 90 70 1 © 2014 BlueStar Global Investors, LLC These are not recommendations to buy or sell any security About the BlueStar Israel Global Index The BlueStar Israel Global Index (’BIGI®’) provides a benchmark for investors to track the broadest and deepest universe of Israeli public companies. The index is constructed using BlueStar Indexes’ unique methodology and proprietary database of Israeli and Israel-linked companies. BIGI® includes the largest and most liquid companies as well as mid and small cap companies that display sufficient liquidity for global investors. The index methodology allows for the inclusion of Israeli companies listed on the Tel Aviv Stock Exchange as well as other exchanges such as the London Stock Exchange, New York Stock Exchange, and NASDAQ. The BlueStar Israel Global Index has been created to provide investors with an investable product allowing them to quickly take advantage of both event-driven news and long-term economic trends as the economy and companies of Israel continue to evolve. Comparative Sector Weights Long- Term Returns* MSCI - FTSE Sector BIGI® TA-25 TA-100 Q2 2014 1yr. 3yrs. 5yrs. 10yrs. 15yrs. Inception1 EIS Israel Information Technology 30.8% 6.1% 1.6% 4.5% 8.1% ACWI 5.23% 23.58% 10.85% 14.88% 8.02% 4.88% 8.29% Health Care 29.9% 25.1% 27.9% 24.8% 26.0% EAFE 4.34% 24.09% 8.59% 12.27% 7.42% 5.03% 7.27% Financials 19.0% 36.6% 10.0% 31.9% 31.5% MSCI EM 6.71% 14.68% -0.06% 9.58% 12.30% 9.21% 8.34% Materials 5.4% 10.4% 3.3% 8.8% 7.3% Energy 4.5% 5.6% 2.0% 14.8% 12.0% S&P 500 5.23% 24.61% 16.58% 18.83% 7.78% 4.35% 9.35% Telecom. Services 3.4% 7.3% 2.7% 9.7% 7.1% MSCI Israel 2.41% 32.52% 0.74% 4.61% 6.47% 6.87% 6.39% Industrials 2.7% 5.0% 1.3% 2.8% 4.2% TA-100 -0.58% 24.16% 3.88% 12.32% 10.67% 8.83% 7.89% Consumer Discretionary 2.0% 0.6% 0.2% 0.0% 1.3% TA-25 0.78% 23.81% 4.15% 12.97% 12.56% 9.58% 8.19% Consumer Staples 1.8% 3.4% 1.0% 2.8% 2.6% Utilities 0.5% 0.0% 0.0% 0.0% 0.0% BlueStar -1.60% 25.95% 5.41% 13.64% 11.45% - - Source: BlueStar Global Investors LLC *Annualized Jun. 30, 2014 1Inception Date: Dec. 1992 Source: BlueStar Global Investors LLC Jun. 30, 2014 Comparative Risk (Standard Deviation of Returns)* Five Year Correlations MSCI Q2 2014 1yr. 3yrs. 5yrs. 10yrs. 15yrs. Inception1 ACWI MSCI EM EAFE S&P 500 TA-100 TA-25 Israel ACWI 2.19% 9.69% 14.26% 14.99% 16.61% 16.40% 15.41% ACWI 1.00 EAFE 1.35% 11.02% 16.30% 17.00% 18.25% 17.54% 16.69% MSCI EM 0.90 1.00 MSCI EM 5.65% 12.34% 19.49% 19.16% 23.77% 23.14% 23.45% EAFE 0.97 0.86 1.00 S&P 500 2.98% 9.47% 12.26% 13.40% 14.70% 15.39% 14.79% S&P 500 0.96 0.81 0.89 1.00 MSCI Israel 9.06% 11.43% 19.40% 18.85% 18.89% 24.18% 23.65% MSCI Israel 0.69 0.71 0.63 0.66 1.00 TA-100 4.64% 11.69% 16.79% 18.53% 21.56% 23.97% 24.14% TA-100 0.78 0.79 0.75 0.73 0.86 1.00 TA-25 3.33% 13.63% 17.44% 19.03% 21.78% 24.25% 24.20% TA-25 0.78 0.80 0.74 0.72 0.84 0.99 1.00 BlueStar 10.47% 10.68% 16.86% 18.27% 19.94% - - BlueStar 0.82 0.80 0.78 0.77 0.87 0.97 0.95 *Annualized 1Inception Date: Dec. 1992 Source: BlueStar Global Investors LLC Jun. 30, 2014 Source: BlueStar Global Investors LLC Jun. 30, 2014 2 © 2014 BlueStar Global Investors, LLC These are not recommendations to buy or sell any security BlueStar Israel Global Index Constituents and Weights Index Weight as Index Weight as Company Name Ticker Exchange Company Name Ticker Exchange of June. 30, 2014 of Jun. 30, 2014 1 Teva Pharmaceutical Industries TEVA IT 12.63% 58 Mazor Robotics Ltd. MZOR IT 0.35% 2 Perrigo Company plc PRGO UN 11.23% 59 Syneron Medical Ltd ELOS UQ 0.35% 3 Check Point Software (US) CHKP UQ 6.07% 60 Rami Levi Chain Stores. RMLI IT 0.35% 4 Amdocs Ltd DOX UQ 4.74% 61 Ceva Inc CEVA UQ 0.35% 5 Bank Hapoalim BM Reg POLI IT 3.84% 62 Nova Measuring Instruments NVMI IT 0.35% 6 Bank Leumi Le-Israel BM LUMI IT 3.45% 63 Menorah Insurance Co Ltd 1 MMHD IT 0.32% 7 Stratasys Ltd SSYS UQ 3.09% 64 888 Holdings Plc 888 LN 0.32% 8 VeriFone Systems Inc PAY UN 2.46% 65 Oil Refineries Ltd ORL IT 0.32% 9 Israel Chemical Corp ICL IT 2.44% 66 Alon Usa Energy ALJ UN 0.32% 10 BEZEQ ISRAELI TELECOM CORP BEZQ IT 2.37% 67 Telit Communications Plc TCM LN 0.32% 11 VERINT SYSTEMS VRNT UQ 1.67% 68 Naphtha Israel Petroleum NFTA IT 0.30% 12 Nice Systems Ltd NICE IT 1.64% 69 Audiocodes Ltd AUDC UQ 0.30% 13 Israel Corp ILCO IT 1.44% 70 Electra (Israel) ELTR IT 0.30% 14 Playtech PTEC LN 1.35% 71 Delta-Galil Industries DELT IT 0.30% 15 Taro Pharmaceutical Industries TARO UN 1.27% 72 Shufersal Ltd. SAE IT 0.29% 16 Delek Group Ltd DLEKG IT 1.24% 73 Varonis Systems Inc VRNS UQ 0.29% 17 Opko Health Inc OPK UN 1.19% 74 Africa Israel Properties AFPR IT 0.29% 18 Mizrahi Tefahot Bank Ltd MZTF IT 1.18% 75 Clicksoftware Technologies CKSW UQ 0.29% 19 Israel Discount Bank 0.1 DSCT IT 1.09% 76 Africa-Israel Inv Ltd AFIL IT 0.28% 20 Delek US Holdings DK UN 1.08% 77 Silicom Limited SILC UQ 0.28% 21 Elbit Systems Ltd ESLT IT 1.01% 78 Israel Phoenix Assurance 1 PHOE1 IT 0.28% 22 MELLANOX TECH MLNX UQ 0.90% 79 Perion Network Ltd PERI UQ 0.27% 23 Caesar Stone Sdot Yam Ltd CSTE UQ 0.83% 80 Matrix MTRX IT 0.27% 24 Paz Oil Company Ltd PZOL IT 0.76% 81 Formula Systems (1985) Ltd FORT IT 0.27% 25 Gazit Globe 1982 Ltd GZT IT 0.75% 82 DSP Group DSPG UQ 0.26% 26 Azrieli Group AZRG IT 0.74% 83 FIBI Hldgs FIBI IT 0.26% 27 Frutarom FRUT IT 0.72% 84 Discount Investment Corp DISI IT 0.26% 28 Osem Investment OSEM IT 0.60% 85 SafeCharge International SCH LN 0.26% 29 Ezchip Semiconduct EZCH IT 0.60% 86 Bayside LandCorp 1 BYSD IT 0.26% 30 Strauss Group STRS IT 0.58% 87 Mivtach Shamir Hldgs Ltd MISH IT 0.26% 31 Wix.com Ltd WIX UQ 0.56% 88 Magic Software Enterprises MGIC IT 0.26% 32 Radware Ltd RDWR UQ 0.54% 89 PLURISTEM THERAP PSTI UQ 0.26% 33 Harel Insurance Inv Ltd 1 HARL IT 0.53% 90 Sapiens Intl Corp SPNS UQ 0.26% 34 Cellcom Israel Ltd.
Load more

Recommended publications
  • The Advisory Committee for the FTSE Med-100 Index, Had Its Semi-Annual Meeting Today, 14Th of November 2012
    The Advisory Committee for the FTSE Med-100 Index, had its semi-annual meeting today, 14th of November 2012. The FTSE Med-100 Index which was launched on the 19/6/2003 is composed of 100 stocks of three Exchanges (Athens Exchange, Tel-Aviv Stock Exchange and Cyprus Stock Exchange). The Advisory Committee of the index is comprised of representatives from the three Exchanges and also from the global index provider “FTSE Group”. During this meeting, the committee reviewed the operation of the index for the six months period between May 2012 – October 2012, in accordance with its ground rules, which follow international standards. Having applied the index rules, no changes are applicable in the constituent list of the index. The index is composed of 65 stocks listed on the Tel-Aviv Stock Exchange, 22 stocks listed on the Athens Exchange and 13 stocks listed on the Cyprus Stock Exchange. The list of the constituent 100 companies is as follows: Country Capital value (Euro million) 1 Teva Pharmaceutical Israel 27.292,7 2 Israel Chemicals Israel 12.219,9 3 Coca-Cola HBC Greece 6.031,4 4 Israel Corporation Israel 4.035,7 5 Bank Hapoalim Israel 3.986,6 6 Bank Leumi Israel 3.646,5 7 Bezeq Israel 2.556,6 8 Azrieli Group Israel 2.097,3 9 Mellanox Technologies Israel 1.947,6 10 Hellenic Petroleum (Cr) Greece 1.845,0 11 Natl Bank Of Greece Greece 1.710,1 12 Hellenic Telecom Greece 1.670,3 13 Delek Group Israel 1.668,5 14 Nice Systems Israel 1.603,7 15 Mizrahi Tefahot Bank Ltd.
    [Show full text]
  • White Phosphorus (WP) and Smoke Mortars in 60Mm, 81Mm and 120Mm Calibers, Equipped with Point Detonating, Proximity and Electronic Time Fuses
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2010 Commission File No. 0-28998 ELBIT SYSTEMS LTD. (Exact name of registrant as specified in its charter and translation of registrant’s name into English) Israel (Jurisdiction of incorporation or organization) Advanced Technology Center, Haifa 31053, Israel (Address of principal executive offices) Joseph Gaspar c/o Elbit Systems Ltd. P.O. Box 539 Advanced Technology Center Haifa 31053 Israel Tel: 972-4-831-6404 Fax: 972-4-831-6944 E-mail: [email protected] (Name, telephone, e-mail and/or facsimile number and address of Company contact person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Ordinary Shares, nominal value 1.0 New Israeli Shekels per share (Title of Class) The NASDAQ Global Select Market (Name of each Exchange on which registered) Securities registered or to be registered pursuant to Section 12(g) of the Act: Not Applicable Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Not Applicable Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 42,693,340 Ordinary Shares Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
    [Show full text]
  • 2013 Annual Report on Form 10-K
    Annual Report 13 Create Meaningful Connections About LivePerson LivePerson, Inc. (NASDAQ: LPSN, TASE: LPSN) offers a cloud-based platform that enables businesses to proactively connect in real-time with their customers via chat, voice, and content delivery at the right time, through the right channel, including websites, social media, and mobile devices. This "intelligent engagement" is driven by real-time behavioral analytics, producing connections based on a true understanding of business objectives and customer needs. More than 8,500 companies rely on LivePerson's platform to increase conversions and improve customer experience, including Cisco, Hewlett-Packard, IBM, Microsoft, Verizon, Sky, Walt Disney, PNC and Orbitz. LivePerson is headquartered in New York City with offices in Atlanta, Amsterdam, London, Melbourne, San Francisco, Santa Monica, Tokyo and Tel Aviv. Annual Revenue (in millions) Quarterly Revenue (in millions) 2011 2012 2013 $180 $50 46.9 178 45.2 $160 $45 43.2 42.5 42.5 157 $40 39.7 $140 38.5 36.8 36.5 $35 34.3 133 31.9 $120 30.4 $30 $100 110 $25 $80 87 $20 $60 $15 $40 $10 $20 2009 2010 2011 2012 2013 Q1 Q2 Q3 Q4 Safe Harbor Statement Statements in this report regarding LivePerson that are not historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including but not limited to financial guidance, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
    [Show full text]
  • Elbit Medical Technologies Initiation of Coverage
    Elbit Medical Technologies Initiation of coverage Two promising private assets Pharma & biotech 28 June 2018 Elbit Medical Technologies is an Israel-based healthcare investment company traded on the TASE. It is invested in two private companies: Price* NIS1.12 InSightec is a commercial-stage medical device company marketing a non- Market cap NIS259m invasive thermal tissue ablation therapy in three indications and Gamida *Priced as at 26 June 2018 Cell is a cell and immune therapy company developing a universal bone NIS3.64/US$ marrow transplant (BMT) product for haematological malignancies. Net debt ($m) at 31 December 2017 42.4 Although their recent offerings of NIS182m of convertible notes lengthen Shares in issue 231.4m the cash runway it raises the prospect of dilution in 2022. In addition, the Free float 10.8% parent company Elbit Imaging (~89% owned) has its own challenges. We value Elbit Medical at NIS407m or NIS1.76 per share. Code EMTC Primary exchange TASE Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end ($m) ($m) ($) ($) (x) (%) 12/15 1.8 (1.1) 0.0 0.0 N/A N/A Share price performance 12/16 0.0 (3.7) 0.0 0.0 N/A N/A 12/17 0.0 (5.2) 0.0 0.0 N/A N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. InSightec: A non-invasive operating room Elbit Medical currently holds a ~22% (~19% fully diluted) stake in InSightec, a commercial-stage medical device company.
    [Show full text]
  • NASDAQ Stock Market
    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
    [Show full text]
  • Israel and the Alien Tort Statute
    Summer 2014 No.54 JTheUSTICE magazine of the International Association of Jewish Lawyers and Jurists In this issue The International Court of Justice Adjudicating the Arab-Israel Disputes? Boycotts, Divestment, Sanctions and the Law Israel and the Alien Tort Statute Corporations and Human Rights Zivotofsky v. Kerry - A Historical Constitutional Battle Preachers of Hate and Freedom of Expression UNRWA Panel at UN IAJLJ Activities The International Association of Jewish Lawyers and Jurists Honorary President: Hadassa Ben-Itto, Judge (Ret.) (Israel) Life time Member: Irwin Cotler, Prof. (Canada) Honorary Vice Presidents: Joseph Roubache (France) Oreste Bisazza Terracini, Dr. (Italy) Executive Committee: Board of Governors: President: Irit Kohn (Israel) Irit Kohn (Israel) Haim Klugman (Israel) Avraham (Avi) D. Doron (Israel) Deputy President: Meir Rosenne, Dr. (Israel) Haim Klugman (Israel) Mirella M. Bamberger (Israel) Alyza D. Lewin (USA) Vice President and Treasurer: Marcos Arnoldo Grabivker, Judge (Argentina) Avraham (Avi) D. Doron (Israel) Maurizio Ruben (Italy) Alex Hertman (Israel) Vice President and Coordinator with Amos Shapira, Prof. (Israel) International Organizations: Avishai Sapir (Israel) Meir Rosenne, Dr. (Israel) David Pardes (Belgium) Dov Shefi, Brig. (Ret.) (Israel) Vice President and Secretary General: Edna Bekenstein, Judge (Ret.) (Israel) Mirella M. Bamberger (Israel) Edna Kaplan-Hagler, Judge (Ret.) Dr. (Israel) Efraim (Efi) Chalamish, Dr. (USA) Vice Presidents: Ethia Simha (Israel) Alyza D. Lewin (USA) Jeremy D. Margolis (USA) Marcos Arnoldo Grabivker, Judge (Argentina) Jimena Bronfman (Chile) Maurizio Ruben (Italy) Jonathan Lux (UK) Lipa Meir, Dr. (Israel) Academic Adviser: Mala Tabory, Dr. (Israel) Yaffa Zilbershats, Prof. (Israel) Maria Canals De-Cediel, Dr. (Switzerland) Meir Linzen (Israel) Representatives to the U.N.
    [Show full text]
  • List of Section 13F Securities
    List of Section 13F Securities 1st Quarter FY 2004 Copyright (c) 2004 American Bankers Association. CUSIP Numbers and descriptions are used with permission by Standard & Poors CUSIP Service Bureau, a division of The McGraw-Hill Companies, Inc. All rights reserved. No redistribution without permission from Standard & Poors CUSIP Service Bureau. Standard & Poors CUSIP Service Bureau does not guarantee the accuracy or completeness of the CUSIP Numbers and standard descriptions included herein and neither the American Bankers Association nor Standard & Poor's CUSIP Service Bureau shall be responsible for any errors, omissions or damages arising out of the use of such information. U.S. Securities and Exchange Commission OFFICIAL LIST OF SECTION 13(f) SECURITIES USER INFORMATION SHEET General This list of “Section 13(f) securities” as defined by Rule 13f-1(c) [17 CFR 240.13f-1(c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [17 CFR 240.13f-1] under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of March 15, 2004, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending March 31, 2004. Institutional investment managers should report holdings--number of shares and fair market value--as of the last day of the calendar quarter as required by Section 13(f)(1) and Rule 13f-1 thereunder.
    [Show full text]
  • Putnam Panagora Market Neutral Fund Q3 Portfolio Holdings
    Putnam PanAgora Market Neutral Fund The fund's portfolio 5/31/20 (Unaudited) INVESTMENT COMPANIES (46.1%)(a) Shares Value Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. 640 $3,635 State Street Institutional U.S. Government Money Market Fund 3,939,067 3,939,067 Total investment companies (cost $3,943,561) $3,942,702 UNITS (11.0%)(a) Units Value Acamar Partners Acquisition Corp.(NON) 419 $4,291 Alussa Energy Acquisition Corp. (Cayman Islands)(NON) 856 8,483 Amplitude Healthcare Acquisition Corp.(NON) 2,947 29,529 B. Riley Principal Merger Corp. II(NON) 2,620 26,174 CC Neuberger Principal Holdings I(NON) 2,652 27,024 Chardan Healthcare Acquisition 2 Corp.(NON) 2,652 26,493 CHP Merger Corp.(NON) 2,747 27,745 CIIG Merger Corp.(NON) 4,529 45,335 Collective Growth Corp.(NON) 2,803 27,890 DFP Healthcare Acquisitions Corp.(NON) 2,866 28,746 dMY Technology Group, Inc.(NON) 2,885 29,196 East Stone Acquisition Corp.(NON) 4,230 42,089 FinServ Acquisition Corp.(NON) 831 8,194 Foley Trasimene Acquisition Corp.(NON) 2,626 26,917 Fortress Value Acquisition Corp.(NON) 2,652 26,547 Galileo Acquisition Corp.(NON) 888 8,827 GigCapital3, Inc.(NON) 2,833 28,160 Gores Holdings IV, Inc.(NON) 1,306 13,844 Greenrose Acquisition Corp.(NON) 3,350 32,931 GX Acquisition Corp.(NON) 417 4,233 Healthcare Merger Corp.(NON) 2,705 28,105 InterPrivate Acquisition Corp.(NON) 2,918 29,180 Jaws Acquisition Corp.(NON) 2,620 27,038 Juniper Industrial Holdings, Inc.(NON) 841 8,418 Landcadia Holdings II, Inc.(NON) 1,165 12,174 LGL Systems Acquisition Corp.(NON) 2,568 25,629 Lifesci Acquisition Corp.(NON) 2,866 29,806 LIV Capital Acquisition Corp.
    [Show full text]
  • Retirement Funds June 30, 2012 Description % of Shares Owned
    Retirement Funds June 30, 2012 Description % of Shares Owned BARCLAYS LOW CAP PRINCIPAL CAS 0.000000% BLACKROCK FEDFUND(30) 0.440244% BLACKROCK TEMPCASH-FUND(21) 0.000000% BLACKROCK TEMPCASH-FUND(21) 0.000486% BLACKROCK TEMPCASH-FUND(21) 0.000485% BLACKROCK TEMPCASH-FUND(21) 0.008246% BLACKROCK TEMPCASH-FUND(21) 0.006791% BLACKROCK TEMPCASH-FUND(21) 0.005165% BLACKROCK TEMPCASH-FUND(21) 0.006043% BLACKROCK TEMPCASH-FUND(21) 0.004035% BLACKROCK TEMPCASH-FUND(21) 0.035990% BLACKROCK TEMPCASH-FUND(21) 0.020497% BLACKROCK TEMPCASH-FUND(21) 0.023343% BLACKROCK TEMPCASH-FUND(21) 0.008326% BLACKROCK TEMPCASH-FUND(21) 0.000781% BLACKROCK TEMPCASH-FUND(21) 0.004848% BLACKROCK TEMPCASH-FUND(21) 0.022593% BLACKROCK TEMPCASH-FUND(21) 0.000646% BLACKROCK TEMPCASH-FUND(21) 1.307615% BLACKROCK TEMPCASH-FUND(21) 0.214356% BLACKROCK TEMPCASH-FUND(21) 0.001147% BLACKROCK TEMPCASH-FUND(21) 0.024810% BLACKROCK TEMPCASH-FUND(21) 0.009406% BLACKROCK TEMPCASH-FUND(21) 0.018922% BLACKROCK TEMPCASH-FUND(21) 0.030062% BLACKROCK TEMPCASH-FUND(21) 0.010464% BLACKROCK TEMPCASH-FUND(21) 0.004697% BLACKROCK TEMPCASH-FUND(21) 0.001179% BLACKROCK TEMPCASH-FUND(21) 0.007266% BLACKROCK TEMPCASH-FUND(21) 0.000112% BLACKROCK TEMPCASH-FUND(21) 0.008062% BLACKROCK TEMPCASH-FUND(21) 0.011657% CASH COLLATERAL AT BR TRUST 0.000001% CASH COLLATERAL AT BR TRUST 0.000584% EOD STIF 0.024153% MONEY MARKET FD FOR EBT 0.000000% US DOLLAR CASH 0.008786% United States-Dollar 0.000000% United States-Dollar 0.000003% United States-Dollar 0.000019% United States-Dollar 0.000003% United States-Dollar
    [Show full text]
  • Alphabetical Listing by Company Name
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2015 Alphabetical Listing by Company Name COMPANY COUNTRY MARKET 21 Vianet Group Inc. Cayman Islands Global Market 37 Capital Inc. Canada OTC 500.com Ltd. Cayman Islands NYSE 51Job, Inc. Cayman Islands Global Market 58.com Inc. Cayman Islands NYSE ABB Ltd. Switzerland NYSE Abbey National Treasury Services plc United Kingdom NYSE - Debt Abengoa S.A. Spain Global Market Abengoa Yield Ltd. United Kingdom Global Market Acasti Pharma Inc. Canada Capital Market Acorn International, Inc. Cayman Islands NYSE Actions Semiconductor Co. Ltd. Cayman Islands Global Market Adaptimmune Ltd. United Kingdom Global Market Adecoagro S.A. Luxembourg NYSE Adira Energy Ltd. Canada OTC Advanced Accelerator Applications SA France Global Market Advanced Semiconductor Engineering, Inc. Taiwan NYSE Advantage Oil & Gas Ltd. Canada NYSE Advantest Corp. Japan NYSE Aegean Marine Petroleum Network Inc. Marshall Islands NYSE AEGON N.V. Netherlands NYSE AerCap Holdings N.V. Netherlands NYSE Aeterna Zentaris Inc. Canada Capital Market Affimed N.V. Netherlands Global Market Agave Silver Corp. Canada OTC Agnico Eagle Mines Ltd. Canada NYSE Agria Corp. Cayman Islands NYSE Agrium Inc. Canada NYSE AirMedia Group Inc. Cayman Islands Global Market Aixtron SE Germany Global Market Alamos Gold Inc. Canada NYSE Alcatel-Lucent France NYSE Alcobra Ltd. Israel Global Market Alexandra Capital Corp. Canada OTC Alexco Resource Corp. Canada NYSE MKT Algae Dynamics Corp. Canada OTC Algonquin Power & Utilities Corp. Canada OTC Alianza Minerals Ltd. Canada OTC Alibaba Group Holding Ltd. Cayman Islands NYSE Allot Communications Ltd. Israel Global Market Almaden Minerals Ltd.
    [Show full text]
  • Vanguard Total World Stock Index Fund Annual Report October 31, 2020
    Annual Report | October 31, 2020 Vanguard Total World Stock Index Fund See the inside front cover for important information about access to your fund’s annual and semiannual shareholder reports. Important information about access to shareholder reports Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of your fund’s annual and semiannual shareholder reports will no longer be sent to you by mail, unless you specifically request them. Instead, you will be notified by mail each time a report is posted on the website and will be provided with a link to access the report. If you have already elected to receive shareholder reports electronically, you will not be affected by this change and do not need to take any action. You may elect to receive shareholder reports and other communications from the fund electronically by contacting your financial intermediary (such as a broker-dealer or bank) or, if you invest directly with the fund, by calling Vanguard at one of the phone numbers on the back cover of this report or by logging on to vanguard.com. You may elect to receive paper copies of all future shareholder reports free of charge. If you invest through a financial intermediary, you can contact the intermediary to request that you continue to receive paper copies. If you invest directly with the fund, you can call Vanguard at one of the phone numbers on the back cover of this report or log on to vanguard.com. Your election to receive paper copies will apply to all the funds you hold through an intermediary or directly with Vanguard.
    [Show full text]
  • Dimensional Funds PLC
    Dimensional Funds PLC Semi-Annual Report and Accounts 31 May 2012 Authorised and Regulated by the Financial Services Authority 1 No marketing notification has been submitted in Germany for the following sub-funds of Dimensional Funds PLC: European Core Equity Fund Sterling Inflation Linked Intermediate Duration Fixed Income Fund Sterling Inflation Linked Long Duration Fixed Income Fund U.S. Value Fund Sterling Ultra Short Fixed Income Fund Multi-Factor Conservative Fund Multi-Factor Balanced Fund Accordingly, these sub-funds must not be publicly marketed in Germany. 1 DIMENSIONAL FUNDS PLC Table of Contents Page General Information..................................................................................................................................................................................................................... 2 Investment Manager’s Reports .................................................................................................................................................................................................... 3 Balance Sheet ............................................................................................................................................................................................................................. 12 Profit and Loss Account............................................................................................................................................................................................................. 16 Statement
    [Show full text]